Skip to main content
ConvictionStocks
ScreenerEarningsLearn
1D1W1M3M1Y5YMAX
                      

Healthcare

Supernus Pharmaceuticals, Inc.

SUPN
$42.92+3.72%

Price is delayed.

Add to watchlist

About Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals develops and sells prescription drugs to treat brain and nervous system diseases. Their approved medications include Qelbree for ADHD, several drugs for Parkinson's disease symptoms, and drugs for epilepsy and migraines. The company also has experimental drugs in testing for conditions like epilepsy, depression, and ADHD. They sell their products through pharmaceutical wholesalers and specialty pharmacies.

1D1W1M3M1Y5YMAX
                      
Loading chart...

Chart powered by TradingView Lightweight Charts

ConvictionStocks logo

Plain-English investing education for people who want to understand what they own.

Product

  • Features
  • Pricing
  • Screener
  • Earnings

Resources

  • Learn
  • Glossary

Company

  • Terms of Service
  • Privacy Policy
  • Contact us

ConvictionStocks is for informational purposes only and does not constitute financial advice. We are not a registered investment advisor. Past performance does not guarantee future results.

© 2026 ConvictionStocks. All rights reserved.

Members only

Full research is for ConvictionStocks members

Members read the rest of this page. Where we have it for this company, that is:

  • What each number means, in plain English, with the Wall Street name where the two differ.
  • A plain-English summary of the company.
  • How many analysts cover it, and the count behind each rating.
  • Recent news, dated.
Get full accessSee a sample company page in full

Get the free weekly market digest

The week's biggest movers, every Sunday. No spam.

                                                                                          

Look up another company

No tickers found

Related Research

More Healthcare stocks to explore

MRK

Merck & Co., Inc.

NVO

Novo Nordisk A/S

ABT

Abbott Laboratories

PFE

Pfizer Inc.

BMY

Bristol-Myers Squibb Company